FDA Approved: SUNLENCA — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

This document reports an FDA supplemental application submission for Sunlenca (lenacapavir sodium) by Gilead Sciences, Inc., with the submission status noted as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• SUNLENCA (LENACAPAVIR SODIUM)

Snippet

SUPPL AP for SUNLENCA (LENACAPAVIR SODIUM)